Richard Davis

Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man.

Thierry H. LeJemtel, Edmund C. Keung, Edmund H. Sonnenblick et al. · Circulation · 1979 · 216 citations · Full text

Hypertension, Heart Failure, Cardiovascular Pharmacology +18

Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure

Thierry H. LeJemtel, Edmund C. Keung, Hillel S. Ribner et al. · The American Journal of Cardiology · 1980 · 105 citations

Heart Failure, Renal Function, Cardiovascular Disease +11

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 6. A comparison of pindolol and propranolol in treatment of patients with angina pectoris. The role of intrinsic sympathomimetic activity

William H. Frishman, John B. Kostis, Joel A. Strom et al. · American Heart Journal · 1979 · 71 citations

Adrenal Gland, Cardiovascular Disease, Medicine +10

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 5. Pindolol (LB-46) therapy for supraventricular arrhythmia: a viable alternative to propranolol in patients with bronchospasm

William H. Frishman, Richard Davis, Joel A. Strom et al. · American Heart Journal · 1979 · 48 citations

Cardiovascular Disease, Medicine, Physiology +9

Right ventricular adaptation to increased afterload after orthotopic cardiac transplantation in the setting of recipient chronic pulmonary hypertension.

Edward P. Chen, H Bittner, Richard Davis et al. · PubMed · 1997 · 16 citations